Thymectomy for non-thymomatous myasthenia gravis

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Cea, Gabriel ^a   Benatar, Michael ^b   Verdugo, Renato J ^c   Salinas, Rodrigo A ^d  

^a UNIVERSITY OF CHILE   (Chile)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF CHILE   (Chile)

^d INSTITUTO DE SALUD PÚBLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTISONE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; PREDNISOLONE; PYRIDOSTIGMINE;

HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MYASTHENIA GRAVIS; NON THYMOMATOUS MYASTHENIA GRAVIS; OUTCOME ASSESSMENT; PATHOGENESIS; REVIEW; SYSTEMATIC REVIEW; THERAPY EFFECT; THYMECTOMY;

EID: 77950105986     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008111     Document Type: Review

References (19)

1. Burns 2008 Burns TM, Conaway MR, Cutter GR, Sanders DB. Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite. Muscle & Nerve 2008;38(6):1553-62. [PUBMED: 19016543]
2. Gajdos 2002 Gajdos P, Chevret S, Toyka K. Plasma exchange for myasthenia gravis. Cochrane Database of Systematic Reviews 2002, Issue 4. [DOI: 10.1002/14651858]
3. Gajdos 2008 Gajdos P, Chevret S, Toyka K. Intravenous immunoglobulin for myasthenia gravis. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858]
4. Gronseth 2000 Gronseth GS, Barohn RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55(1):7-15. [PUBMED: 10891896]
5. Hart 2007 Hart I K, Sathasivam S, Sharshar T. Immunosuppressive agents for myasthenia gravis. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858]
6. Higgins 2008 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochranehandbook.org.
7. Jaretzki 2000 Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al.Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 2000;55(1):16- 23. [PUBMED: 10891897]
8. Kaminski 2003 Kaminski HJ. Myasthenia Gravis and Related Disorders. Totowa, NJ: Humana Press, 2003.
9. Lanska 1990 Lanska DJ. Indications for thymectomy in myasthenia gravis. Neurology 1990;40(12):1828-9. [PUBMED: 2247228]
10. McQuillen 1977 McQuillen MP, Leone MG. A treatment carol: thymectomy revisited. Neurology 1977; Vol. 27, issue 12:1103-6. [PUBMED: 563009]
11. NCT00294658 NCT00294658. A multi-center, single-blind, randomized study comparing thymectomy to no thymectomy in non-thymomatous myasthenia gravis (MG) patients receiving prednisone. http://clinicaltrials.gov/ct2/show/ NCT00294658 Accessed April 7 2009.
12. Newsom-Davis 1981 Newsom-Davis J, Willcox N, Scadding G, Calder L, Vincent A. Anti-acetylcholine receptor antibody synthesis by cultured lymphocytes in myasthenia gravis: thymic and peripheral blood cell interactions. Annals of the New York Academy of Sciences 1981;377:393-402. [PUBMED: 6978662]
13. Newsom-Davis 2001 Newsom-Davis J, Beeson D. Myasthenia gravis and myasthenic syndromes: autoimmune and genetic disorders. In: Karpati G, Hilton-Jones D, Griggs RC editor(s). Disorders of Voluntary Muscle. Cambridge: Cambridge University Press, 2001:660-75.
14. Penn 1994 Penn AS. Thymectomy for myasthenia gravis. In: Lisak RP editor (s). Handbook of Myasthenia Gravis and Myasthenic syndrome. New York: Marcel Dekker, 1994:321-39.
15. Phillips 2003 Phillips LH 2nd. The epidemiology of myasthenia gravis. Annals of the New York Academy of Sciences 2003;998:407- 12. [PUBMED: 14592908]
16. Schneider-Gold 2005 Schneider-Gold C, Gajdos P, Toyka K V, Hohlfeld R R. Corticosteroids for myasthenia gravis. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858]
17. Schonbeck 1992 Schönbeck S, Padberg F, Hohlfeld R, Wekerle H. Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis. The Journal of clinical investigation 1992;90(1):245-50. [PUBMED: 1634612]
18. Vincent 2001 Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 2001;357(9274):2122-8. [PUBMED: 11445126]
19. Vincent 2007 Vincent KA, Carr AJ, Walburn J, Scott DL, Rose MR. Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL). Neurology 2007;68(13):1051-7. [PUBMED: 17389311]